Patients with metastatic epidural spinal cord compression (MESCC) and favorable survival prognoses may benefit from radiation doses exceeding 10 × 3.0 Gy. In a multi-center phase 2 trial, patients receiving 15 × 2.633 Gy (41.6 Gy(10)) or 18 × 2.333 Gy (43.2 Gy(10)) were evaluated for local progression-free survival (LPFS),... Read more